+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Combination therapy in naive patients with chronic hepatitis C related to genotype 1 Comparison between IFN+Ribavirin and IFN+Amantadine and between Amantadine and Ribavirin addition after 3 months in still viremic patients



Combination therapy in naive patients with chronic hepatitis C related to genotype 1 Comparison between IFN+Ribavirin and IFN+Amantadine and between Amantadine and Ribavirin addition after 3 months in still viremic patients



Hepatology 36(4 Part 2): 573A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034605675

Download citation: RISBibTeXText


Related references

Comparison between IFNalpha2a+Ribavirin and IFNalpha2a+Amantadine combination therapy in naive patients with chronic hepatitis C-genotype 1, and between Amantadine and Ribavirin addition in non responders after 3 months. Journal of Hepatology 36(Suppl. 1): 98, 2002

IFN + ribavirin versus IFN + amantadine in naive patients with chronic hepatitis C and amantadine versus ribavirin addition after 3 months in still viremic patients. Gastroenterology 123(1 Suppl.): 75, 2002

Retreatment of IFN-unresponsive patients with chronic hepatitis C Comparison between peginterferon alfa-2a plus amantadine and interferon alfa-2a plus AMA and evaluation of efficacy of ribavirin addition after 3 months in still viremic patients. Hepatology 36(4 Part 2): 571A, 2002

Comparison between IFN induction, induction+ribavirin and IFN+ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1. Journal of Hepatology 32(Suppl. 2): 110, 2000

Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone. Journal of Clinical Virology 39(1): 54-58, 2007

Comparison between IFN induction therapy, IFN induction+Ribavirin and IFN+Ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1 Final report. Journal of Hepatology 34(Suppl. 1): 148, 2001

Comparison between IFN induction therapy, IFN induction + Ribavirin and IFN + Ribavirin standard combination therapy in naive patients with chronic hepatitis C related to genotype 1. Hepatology 32(4 Pt 2): 366A, 2000

Efficacy of a prolonged alphaInterferon-ribavirin therapy without or with the addition of amantadine in genotype 1b HCV CAH patients non responders to 6-months retreatment with alphaInterferon plus ribavirin because of relapse after alphaInterferon monotherapy. Hepatology 34(4 Pt 2): 581A, 2001

Analyses of 40 kDa peginterferon alfa-2a in combination with ribavirin, mycophenolate mofetil, amantadine, or amantadine plus ribavirin in patients that relapsed or did not respond to RebetronTM therapy A report of two randomized, multicenter, efficacy and safety studies. Hepatology 34(4 Pt 2): 243A, 2001

HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin. Journal of Viral Hepatitis 7(6): 409-413, 2000

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine. Wiener Klinische Wochenschrift 116(15-16): 530-535, 2004

Treatment with amantadine + ribavirin + interferon in patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A143, 2000

Early response to IFN induction therapy, induction + Ribavirin and IFN + Ribavirin combination therapy in naive patients with chronic hepatitis C related to genotype 1. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A142, 2000

A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C. Journal of Gastroenterology 42(5): 362-367, 2007

Interferon alfa2a induction therapy in combination with ribavirin and amantadine in naive patients with chronic HCV infection. Hepatology 36(4 Part 2): 583A, 2002